References
- Kanathur N, Lee-Chiong T. Pulmonary manifestations of ankylosing spondylitis, Clin Chest Med. 2010;31:547–5.
- Trofimenko IN, Nashatyreva MS, Chernyak BA. Pulmonary involvement in ankylosing spondylitis. Pulmonologiya. 2017;27:97–102.
- Franquet T, Müller NL, Flint JD. A patient with ankylosing spondylitis and recurrent haemoptysis. Eur Respir J. 2004;23:488–491.
- El Maghraoui A. Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications. Eur J Intern Med. 2011;22:554–560.
- El Maghraoui A, Dehhaoui M. Prevalence and characteristics of lung involvement on high resolution computed tomography in patients with ankylosing spondylitis: a systematic review. Pulm Med. 2012;2012. doi:10.1155/2012/965956.
- Rumancik M, Leitman S, Mccauley I, et al. Fibrobullous disease of the upper lobes: an extraskeletal manifestation of ankylosing spondylitis. J Comput Tomogr. 1984;8:225–229.
- Kiris A, Ozgocmen S, Kocakoc E, et al. Lung findings on high resolution CT in early ankylosing spondylitis. Eur J Radiol. 2003;47:71–76.
- Hasiloglu ZI. Lung parenchymal changes in patients with ankylosing spondylitis. World J Radiol. 2012;4:215.
- Ulusoy H, Tuna NT, Tanrivermis Sayit A. Rapidly progressive pulmonary apical fibrosis and parenchymal destruction in a patient with ankylosing spondylitis. Case Rep Rheumatol. 2020;2020:1–4.
- Sampaio-Barros PD, Cerqueira EMFP, Rezende SM, et al. Pulmonary involvement in ankylosing spondylitis. Clin Rheumatol. 2007;26:225–230.
- Pamuk ÖN, Harmandar O, Tosun B, et al. A patient with ankylosing spondylitis who presented with chronic necrotising aspergillosis. Clin Rheumatol. 2005;24:415–419.
- Levy H, Hurwitz MD, Strimling M, et al. Spondylitis lung disease and mycobacterium scrofulaceum. Br J Dis Chest. 1988;82:84–87.
- Van der Horst-Bruinsma Irene E. Clinical aspects of ankylosing spondylitis Van Royen, BJ, Dijkmans, BAC. In: Ankylosing Spondylitis. Diagnosis and Management. CRC Press; 2006:45–70.
- Kim DY, Lee SJ, Ryu YJ, et al. Progressive pulmonary fibrocystic changes of both upper lungs in a patient with ankylosing spondylitis. Tuberc Respir Dis. 2015;78:459–462.
- De Keyser F, Van den Bosch F, Mielants H. Anti-TNF-alpha therapy in ankylosing spondylitis. Cytokine. 2006;33:294–298.